Pacira Pharmaceuticals buy Raymond James
Start price
31.07.24
/
50%
€19.10
Target price
31.07.25
€34.20
Performance (%)
-5.24%
End price
01.08.25
€18.10
Summary
This prediction ended on 01.08.25 with a price of €18.10. With a performance of -5.24%, the BUY prediction by Raymond_James finished with a loss. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | 1.523% | 1.523% | -6.542% |
| iShares Core DAX® | 0.444% | 3.030% | 12.677% |
| iShares Nasdaq 100 | 3.819% | 4.073% | 33.152% |
| iShares Nikkei 225® | 1.148% | 6.904% | 45.488% |
| iShares S&P 500 | 2.371% | 2.677% | 25.689% |
Comments by Raymond_James for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at Raymond James from $41.00 to $37.00. They now have an "outperform" rating on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Raymond_James for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€29.60
20.12.23
20.12.23
€38.31
20.12.24
20.12.24
-38.51%
21.12.24
21.12.24
